Cargando…

Combination immunotherapy: Where do we go from here?

The remarkable clinical success of cancer immunotherapies targeting the checkpoint receptors CTLA-4 and PD-1 has generated considerable excitement and emboldened efforts to build on this important foundation. Research efforts are now focused on understanding the mechanism of action of these immunoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Overacre, Abigail E., Kurtulus, Sema, Sznol, Mario, Pardoll, Drew M., Anderson, Ana, Vignali, Dario A. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539723/
http://dx.doi.org/10.1186/s40425-015-0083-z